TMEM186

Chr 16

transmembrane protein 186

Also known as: C16orf51

This gene encodes a potential transmembrane protein. [provided by RefSeq, Dec 2012]

OMIMResearchGenerating clinical summary…
DNmechanismLOEUF 1.58
Clinical SummaryTMEM186
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.58LOEUF
pLI 0.000
Z-score 0.38
OE 0.86 (0.491.58)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-1.25Z-score
OE missense 1.31 (1.161.49)
168 obs / 128.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.86 (0.491.58)
00.351.4
Missense OE?1.31 (1.161.49)
00.61.4
Synonymous OE?1.29
01.21.6
LoF obs/exp: 7 / 8.2Missense obs/exp: 168 / 128.1Syn Z: -1.56

This gene — mechanism propensity

DN
0.74top 25%
GOF
0.5465th %ile
LOF
0.2581th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TMEM186 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →